Drug General Information
Drug ID
D09CGL
Former ID
DNC000514
Drug Name
Daio-Orengedokuto (DOT)
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535601]
Structure
Download
2D MOL

3D MOL

Formula
C14H13NaO3
Canonical SMILES
CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+]
InChI
1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1
InChIKey
CDBRNDSHEYLDJV-FVGYRXGTSA-M
CAS Number
CAS 22204-53-1
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
G02CC02
SuperDrug CAS ID
cas=022204531
Target and Pathway
Target(s) Triacylglycerol lipase, pancreatic Target Info Inhibitor [535601]
BioCyc Pathway Triacylglycerol degradation
Retinol biosynthesis
KEGG Pathway Glycerolipid metabolism
Metabolic pathways
Pancreatic secretion
Fat digestion and absorption
Vitamin digestion and absorption
Reactome Retinoid metabolism and transport
WikiPathways Visual phototransduction
Lipid digestion, mobilization, and transport
References
Ref 535601Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol Pharm Bull. 2002 Nov;25(11):1442-5.
Ref 535601Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol Pharm Bull. 2002 Nov;25(11):1442-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.